Immunoconjugates and immunotoxins for therapy of solid tumors

被引：9
作者：
Hellstrom, I
Trail, P
Siegall, C
Firestone, R
Hellstrom, KE
机构：
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST, SEATTLE, WA 98121 USA
[2] BRISTOL MYERS SQUIBB CO, PRINCETON, NJ 08543 USA
[3] BRISTOL MYERS SQUIBB CO, WALLINGFORD, CT 06492 USA
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1996年 / 38卷
关键词：
D O I：
10.1007/s002800051034
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S35 / S36
页数：2
相关论文
共 14 条
[1]   DRUG IMMUNOTARGETING FOR CARCINOMAS - A REALITY AT LAST [J].
CASAZZA, AM ;
TRAIL, PA ;
HELLSTROM, KE .
ANNALS OF ONCOLOGY, 1994, 5 (08) :703-708
[2]  
FRIEDMAN PN, 1993, CANCER RES, V53, P334
[3]  
FRIEDMAN PN, 1993, J IMMUNOL, V150, P3054
[4]  
Hellstrom I, 1995, Adv Pharmacol, V33, P349, DOI 10.1016/S1054-3589(08)60674-2
[5]   BARRIERS TO DRUG-DELIVERY IN SOLID TUMORS [J].
JAIN, RK .
SCIENTIFIC AMERICAN, 1994, 271 (01) :58-65
[6]   RADIOLABELED-ANTIBODY THERAPY OF B-CELL LYMPHOMA WITH AUTOLOGOUS BONE-MARROW SUPPORT [J].
PRESS, OW ;
EARY, JF ;
APPELBAUM, FR ;
MARTIN, PJ ;
BADGER, CC ;
NELP, WB ;
GLENN, S ;
BUTCHKO, G ;
FISHER, D ;
PORTER, B ;
MATTHEWS, DC ;
FISHER, LD ;
BERNSTEIN, ID .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (17) :1219-1224
[7]   RANDOMIZED TRIAL OF MONOCLONAL-ANTIBODY FOR ADJUVANT THERAPY OF RESECTED DUKES-C COLORECTAL-CARCINOMA [J].
RIETHMULLER, G ;
SCHNEIDERGADICKE, E ;
SCHLIMOK, G ;
SCHMIEGEL, W ;
RAAB, R ;
HOFFKEN, K ;
GRUBER, R ;
PICHLMAIER, H ;
HIRCHE, H ;
PICHLMAYR, R ;
BUGGISCH, P ;
WITTE, J ;
EIGLER, FW ;
FACKLERSCHWALBE, I ;
FUNKE, I ;
SCHMIDT, CG ;
SCHREIBER, H ;
SCHWEIBERER, L ;
EIBLEIBESFELDT, B .
LANCET, 1994, 343 (8907) :1177-1183
[8]  
SIEGALL CB, 1994, J IMMUNOL, V152, P2377
[9]  
SIEGALL CB, 1994, CANCER-AM CANCER SOC, V74, P1006, DOI 10.1002/1097-0142(19940801)74:3+<1006::AID-CNCR2820741506>3.0.CO
[10]  
2-V
12